Table 2 Baseline demographic and clinical subject characteristics
Variable | ST | CPM |
|---|---|---|
|  | (n = 19) | (n = 19) |
Age, yrs | 68.8 (8.0) | 67.1 (8.8) |
Sex, men | 12.0 (63.2%) | 10.0 (52.6%) |
Weight, kg | 88.9 (13.3) | 93.6 (15.9) |
Height, m | 1.69 (0.1) | 1.68 (0.1) |
BMI | 31.1 (4.2) | 33.3 (5.1) |
Affected side, right | 8.0 (42.1%) | 7.0 (36.8%) |
Hypertension | 13.0 (68.4%) | 14.0 (73.7%) |
Cardiac problems | 6.0 (31.6%) | 5.0 (26.3%) |
Pulmonary problems | 1.0 (5.3%) | 0.0 (0%) |
Diabetes | 2.0 (10.5%) | 5.0 (26.3%) |
Cancer | 1.0 (5.3%) | 0.0 (0%) |
TKA contralateral side | 5.0 (26.3%) | 6.0 (31.6%) |
THA contralateral side | 2.0 (10.5%) | 0.0 (0%) |
THA ispilateral side | 3.0 (15.8%) | 1.0 (5.3%) |